Carbapenemase-producing Enterobacteriaceae and non-Enterobacteriaceae from animals and the environment: an emerging public health risk of our own making?
Open Access
- 3 October 2013
- journal article
- review article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 69 (2), 287-291
- https://doi.org/10.1093/jac/dkt392
Abstract
Acquired carbapenemases pose one of the most pressing public health threats relating to antibiotic resistance. In most countries, the number of carbapenemase-producing bacteria from human clinical specimens is rising, and the epidemiological status of these multiresistant bacteria is progressively worsening. Furthermore, there is a growing number of reports of carbapenemases found either in bacteria isolated from non-human sources or in Salmonella enterica subsp. enterica, a zoonotic species. However, carbapenemases are not yet systematically sought in bacteria from non-human sources, reports of them are largely observational, and there is limited investigation of carbapenemase-positive bacteria in animals and possible links with people who may have acted as potential sources. Active surveillance and monitoring for carbapenem-resistant bacteria in the food chain and other non-human sources is urgently needed, with an enhanced and rigorous follow-up of all positive results. The carbapenems are currently our last good defence against multiresistant Gram-negative bacteria. Our ability to limit the rise and spread of carbapenemase producers, which occur only at basal levels in many countries at present, should serve as a key performance indicator for the success or failure of the efforts that have been called for by international organizations and governments to reduce the impact of antibiotic resistance.Keywords
This publication has 38 references indexed in Scilit:
- Highly drug-resistant Salmonella enterica serotype Kentucky ST198-X1: a microbiological studyThe Lancet Infectious Diseases, 2013
- Does adding routine antibiotics to animal feed pose a serious risk to human health?BMJ, 2013
- Annual Report of the Chief Medical Officer: infection and the rise of antimicrobial resistanceThe Lancet, 2013
- Improving the quality of antibiotic prescribing in the NHS by developing a new Antimicrobial Stewardship Programme: Start Smart--Then FocusJournal of Antimicrobial Chemotherapy, 2012
- Rapid evolution and spread of carbapenemases among Enterobacteriaceae in EuropeClinical Microbiology & Infection, 2012
- Origin of OXA-181, an Emerging Carbapenem-Hydrolyzing Oxacillinase, as a Chromosomal Gene in Shewanella xiamenensisAntimicrobial Agents and Chemotherapy, 2011
- Dutch patients, retail chicken meat and poultry share the same ESBL genes, plasmids and strainsClinical Microbiology & Infection, 2011
- Detection of 140 clinically relevant antibiotic-resistance genes in the plasmid metagenome of wastewater treatment plant bacteria showing reduced susceptibility to selected antibioticsMicrobiology, 2009
- Acinetobacter radioresistensas a Silent Source of Carbapenem Resistance forAcinetobactersppAntimicrobial Agents and Chemotherapy, 2008
- Chromosome-Encoded Ambler Class D β-Lactamase ofShewanella oneidensisas a Progenitor of Carbapenem-Hydrolyzing OxacillinaseAntimicrobial Agents and Chemotherapy, 2004